🇺🇸 FDA
Company

BRAINSTORM

BRAINSTORM CELL THERAPEUTICS INC.

BCLI biotech USA

Quick answer

BRAINSTORM is a biotech company (BCLI) headquartered in NEW YORK, NY, USA with 5 tracked pipeline programs.

Pipeline (5)

project

Debamestrocel - MSC-NTF (NurOwn)

Amyotrophic Lateral Sclerosis (ALS)

Phase 3 · mab · active

1 trials project

NurOwn® (MSC-NTF cells)

Amyotrophic Lateral Sclerosis (ALS)

Phase 3 · mab · completed

2 trials project

MSC-NTF cells transplantation (IM)

Amyotrophic Lateral Sclerosis

Phase 2 · mab · completed

1 trials project

MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF

Amyotrophic Lateral Sclerosis

Phase 2 · mab · completed

1 trials project

NurOwn (MSC-NTF cells)

Multiple Sclerosis, Chronic Progressive

Phase 2 · mab · completed

1 trials

Patents (8)

patent

US 12233092

MSC-NTF specific exosomes and use thereof

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11185572

Mesenchymal stem cells for the treatment of CNS diseases

Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10564149

Populations of mesenchymal stem cells that secrete neurotrophic factors

Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10052363

Mesenchymal stem cells for the treatment of CNS diseases

Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10046010

Methods of generating mesenchymal stem cells which secrete neurotrophic factors

Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9474787

Mesenchymal stem cells for the treatment of CNS diseases

Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8900574

Mesenchymal stem cells for the treatment of CNS diseases

Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8663987

Mesenchymal stem cells for the treatment of CNS diseases

Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)